JAVIER MERY: Open Payments
NPI 1518604586 · STERLING, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,753 in 158 payments from 26 companies in 2025. Trend: 2023 $2,072 · 2024 $2,509 · 2025 $3,753
Food & beverage: $3,737Education: $16
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $719 |
| Janssen Biotech, Inc. | 21 | $597 |
| Gilead Sciences, Inc. | 12 | $361 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $241 |
| Ardelyx, Inc. | 12 | $229 |
| Madrigal Pharmaceuticals | 9 | $227 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $196 |
| PFIZER INC. | 8 | $187 |
| Novo Nordisk Inc | 3 | $173 |
| QOL Medical, LLC | 5 | $166 |
Products named: TREMFYA, RINVOQ, IBSRELA, REZDIFFRA, XIFAXAN, Wegovy, Sucraid, CREON.
Industry payments across VA — which companies pay providers there.
